"Orgasm Inc.," which takes viewers behind the scenes in that quest, premieres in theaters in 11 U.S. cities -- New York and Chicago on Feb. 11, and in Los Angeles and San Francisco in April, as well as seven other cities, including Ottawa.
It all began in 2002, when filmmaker Liz Canner took a job with the California-based pharmaceutical company Vivus, which was using her videos to show to women in early clinical trials for a new orgasm drug called Alista.
The timing couldn't have been better:Pfizer had come out with Viagra for men in the late 1990s, and Vivus was scrambling to find a female equivalent. As Canner intercut ocean scenes with descriptions of the clitoris, she began to wonder if company executives were testing a female sex drug for which they didn't yet have a disease.
Soon, she said she realized her employer -- and perhaps the pharmaceutical industry at large -- might be selling women a potentially dangerous product. So Canner switched gears, and with the permission of Vivus, began her own project.
In Orgasm Inc.," her first feature documentary, Canner explores the creation of female sexual dysfunction and the billions of dollars the pharmaceutical companies have poured into promoting drugs to healthy women.
Orgasm Inc., Search for Female Viagra, Premieres in New York, Chicago and Los Angeles - ABC News
via abcnews.go.com
